| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1027556150 |
| P356 | DOI | 10.1007/S12263-010-0180-Z |
| P932 | PMC publication ID | 3040795 |
| P698 | PubMed publication ID | 21437026 |
| P5875 | ResearchGate publication ID | 50851361 |
| P2093 | author name string | Ping Tou Gee | |
| P2860 | cites work | Crystal structure of human alpha-tocopherol transfer protein bound to its ligand: implications for ataxia with vitamin E deficiency | Q24630615 |
| Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways | Q24646599 | ||
| Tocotrienols in health and disease: the other half of the natural vitamin E family | Q24651921 | ||
| The molecular basis of vitamin E retention: structure of human alpha-tocopherol transfer protein | Q27641782 | ||
| Aging: a theory based on free radical and radiation chemistry | Q27860549 | ||
| Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells | Q28142722 | ||
| Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico | Q28143207 | ||
| Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project | Q28176142 | ||
| Dietary alpha-tocopherol decreases alpha-tocotrienol but not gamma-tocotrienol concentration in rats | Q28207428 | ||
| Postprandial levels of the natural vitamin E tocotrienol in human circulation | Q28245711 | ||
| Dietary alpha-tocopherol attenuates the impact of gamma-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens | Q28279072 | ||
| Absorption, transport, and tissue delivery of vitamin E | Q28289897 | ||
| Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis | Q28290519 | ||
| Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality | Q28292632 | ||
| Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination | Q28306635 | ||
| Sebaceous gland secretion is a major physiologic route of vitamin E delivery to skin | Q28377554 | ||
| Alpha-tocopherol transfer protein is important for the normal development of placental labyrinthine trophoblasts in mice | Q28508051 | ||
| Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly | Q28624200 | ||
| Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status | Q32019197 | ||
| A randomized placebo controlled trial of vitamin E for alcoholic hepatitis | Q44691206 | ||
| Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis | Q44742198 | ||
| Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin | Q44985154 | ||
| Depletion of human stratum corneum vitamin E: an early and sensitive in vivo marker of UV induced photo-oxidation | Q46150559 | ||
| Absence of VLDL secretion does not affect alpha-tocopherol content in peripheral tissues | Q46194530 | ||
| Tocotrienols reduce 25-hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules | Q46432121 | ||
| Vitamin E increases biomarkers of estrogen stimulation when taken with tamoxifen | Q46603461 | ||
| Inhibitory effect of tocotrienol on eukaryotic DNA polymerase lambda and angiogenesis. | Q46834018 | ||
| The ABCs of vitamin E and beta-carotene absorption | Q47303550 | ||
| A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study | Q48725577 | ||
| Transport and distribution of alpha-tocopherol in lymph, serum and liver cells in rats. | Q51631763 | ||
| Critique of the requirement for vitamin E. | Q54059523 | ||
| Vitamin E: action, metabolism and perspectives | Q56038941 | ||
| δ-Tocomonoenol: A new vitamin E from kiwi (Actinidia chinensis) fruits | Q57748736 | ||
| Studies on the transfer of tocopherol between lipoproteins | Q58320419 | ||
| Comparison of free alpha-tocopherol and alpha-tocopheryl acetate as sources of vitamin E in rats and humans | Q67959179 | ||
| Preferential incorporation of alpha-tocopherol vs gamma-tocopherol in human lipoproteins | Q69959757 | ||
| IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of tocopherols and related compounds. Recommendations 1981 | Q70336356 | ||
| Effects on health of dietary supplementation with 100 mg d-alpha-tocopheryl acetate, daily for 6 years | Q70807269 | ||
| Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) | Q71060539 | ||
| Lymphatic transport of alpha-, gamma- and delta-tocotrienols and alpha-tocopherol in rats | Q71741247 | ||
| Effects of long-term vitamin E supplementation in alcoholic cirrhotics | Q72334508 | ||
| Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial | Q73176018 | ||
| Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs | Q73450832 | ||
| Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells | Q74239761 | ||
| Postprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of alpha-tocopherol | Q79195140 | ||
| Triton WR1339, an inhibitor of lipoprotein lipase, decreases vitamin E concentration in some tissues of rats by inhibiting its transport to liver | Q79609206 | ||
| Mechanisms involved in vitamin E transport by primary enterocytes and in vivo absorption | Q80507358 | ||
| Tocotrienol levels in adipose tissue of benign and malignant breast lumps in patients in Malaysia | Q80807052 | ||
| Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling | Q33886682 | ||
| An unusual vitamin E constituent (alpha-tocomonoenol) provides enhanced antioxidant protection in marine organisms adapted to cold-water environments | Q33949164 | ||
| Supplementation of Diets with α-Tocopherol Reduces Serum Concentrations of γ- and δ-Tocopherol in Humans | Q34266433 | ||
| Vitamin E supplementation and cataract: randomized controlled trial | Q34288594 | ||
| Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein | Q34296084 | ||
| Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein | Q34308654 | ||
| Biokinetics in humans of RRR-alpha-tocopherol: the free phenol, acetate ester, and succinate ester forms of vitamin E. | Q34368058 | ||
| Human alpha-tocopherol transfer protein: gene structure and mutations in familial vitamin E deficiency | Q34375526 | ||
| Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort. | Q34383377 | ||
| Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial | Q34403303 | ||
| Vitamin E and donepezil for the treatment of mild cognitive impairment | Q34411313 | ||
| High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study | Q34552316 | ||
| The European perspective on vitamin E: current knowledge and future research | Q34905197 | ||
| Vitamin E and drug metabolism | Q35134282 | ||
| Vitamin E and transfer proteins | Q35168815 | ||
| Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up | Q35183061 | ||
| Delivery of orally supplemented alpha-tocotrienol to vital organs of rats and tocopherol-transport protein deficient mice. | Q35676529 | ||
| Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans | Q36256135 | ||
| Intestinal apoproteins during fat absorption | Q36461665 | ||
| Vitamin E metabolism. | Q36738282 | ||
| EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality | Q37174372 | ||
| Antiangiogenic and anticancer potential of unsaturated vitamin E (tocotrienol). | Q37345615 | ||
| Recent progress in understanding apolipoprotein B. | Q37602213 | ||
| Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling | Q39739088 | ||
| Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment | Q39795839 | ||
| Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells | Q40093390 | ||
| Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis | Q40137011 | ||
| In vivo angiogenesis is suppressed by unsaturated vitamin E, tocotrienol | Q40193127 | ||
| Effect of vitamin E on tamoxifen-treated breast cancer cells | Q40225501 | ||
| Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol | Q40250284 | ||
| Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial | Q40577086 | ||
| Quantitative evaluation of vitamin E in the treatment of angina pectoris | Q40754188 | ||
| Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. | Q40894664 | ||
| Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte | Q42488617 | ||
| Supplementary vitamin E does not affect the loss of cartilage volume in knee osteoarthritis: a 2 year double blind randomized placebo controlled study | Q43650009 | ||
| A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group | Q43683334 | ||
| Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers | Q43704054 | ||
| Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). | Q44138520 | ||
| Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study | Q44324611 | ||
| PoleStriding exercise and vitamin E for management of peripheral vascular disease | Q44346846 | ||
| Normal phase high-performance liquid chromatography method for the determination of tocopherols and tocotrienols in cereals. | Q44488634 | ||
| RRR- and SRR-alpha-tocopherols are secreted without discrimination in human chylomicrons, but RRR-alpha-tocopherol is preferentially secreted in very low density lipoproteins | Q44688354 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 5-16 | |
| P577 | publication date | 2010-07-20 | |
| P1433 | published in | Genes & Nutrition | Q19850987 |
| P1476 | title | Unleashing the untold and misunderstood observations on vitamin E. | |
| P478 | volume | 6 |
| Q38167282 | Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management |
| Q53665474 | Anti-inflammatory γ- and δ-tocotrienols improve cardiovascular, liver and metabolic function in diet-induced obese rats. |
| Q21245081 | Bioavailability of tocotrienols: evidence in human studies |
| Q30412296 | Controversies in the Diagnosis and Management of NAFLD and NASH. |
| Q99567276 | Hydrogen inhalation alleviates nonalcoholic fatty liver disease in metabolic syndrome rats |
| Q38747405 | Management of NAFLD: a stage-based approach |
| Q55315481 | Non-alcoholic fatty liver disease: controlling an emerging epidemic, challenges, and future directions. |
| Q28395964 | Rationale for antioxidant supplementation in sarcopenia |
| Q47157084 | Scientific Opinion on Dietary Reference Values for vitamin E as α-tocopherol |
| Q38965196 | Tocotrienol and Its Role in Chronic Diseases. |
| Q36395774 | Tocotrienols reverse cardiovascular, metabolic and liver changes in high carbohydrate, high fat diet-fed rats. |
| Q26851769 | Tocotrienols: the lesser known form of natural vitamin E |
| Q49367065 | Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth? |
| Q38268289 | Vitamin E supplementation and mortality in healthy people: a meta-analysis of randomised controlled trials |
Search more.